UNSPSC 51351903: Etynodiol

This classification denotes an ethynodiol analog, synthetic progestational hormone, and oral contraceptive with the molecular formula C20H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9E01C36A9S, chemically known as 19-norpregn-4-en-20-yne-3,17-diol, diacetate, (3beta,17alpha)- but generally known as etynodiol, which bears US NIH Compound Identifier 9270. European Medicines Agency schedules Etynodiol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07350MIG.

UNSPSC 51351903 Etynodiol, a Commodity code, addresses procurement of the synthetic progestin compound used primarily in oral contraceptive formulations and hormone replacement therapies. State and local governments purchase etynodiol as a bulk pharmaceutical ingredient or finished pharmaceutical product through their health departments, corrections systems, public health clinics, and affiliated medical facilities. The code covers both raw active pharmaceutical ingredient (API) procurement for in-house compounding or contracted manufacturing and finished oral dosage forms (tablets, capsules) for direct dispensing to patients in public health settings.

The source provided contains no recent state and local contract opportunities tagged to this code. Without posted RFP, RFQ, IFB, or ITB activity in the available record, no geographic concentration, issuing-body mix, or representative solicitations can be identified.